Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Net revenues $ 2,507,794 $ 14,135,132
Cost of sales 1,805,739 2,293,050
Gross profit 702,055 11,842,082
Operating expenses:    
Research and development 18,744,349 10,081,161
Selling, general and administrative 17,545,865 6,723,206
Total operating expenses 36,290,214 16,804,367
Operating loss (35,588,159) (4,962,285)
Non-operating income (expenses):    
Interest expense (873,230) (1,158,682)
Change in fair value of derivative liabilities (670,000) (209,000)
Other income, net 220,932 64,616
Total non-operating expenses (1,322,298) (1,303,066)
Loss before income taxes (36,910,457) (6,265,351)
Income tax (benefit) expense (68,278) 114,655
Net loss $ (36,842,179) $ (6,380,006)
Net loss per basic common shares outstanding $ (0.46) $ (0.08)
Basic weighted average common shares outstanding 80,558,670 80,023,168
Net loss per diluted common share outstanding $ (0.46) $ (0.08)
Diluted weighted average common shares outstanding 80,558,670 80,023,168